Medical Properties Trust (MPW) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

MPW Stock Forecast


Medical Properties Trust stock forecast is as follows: an average price target of $11.33 (represents a 165.96% upside from MPW’s last price of $4.26) and a rating consensus of 'Hold', based on 11 wall street analysts offering a 1-year stock forecast.

MPW Price Target


The average price target for Medical Properties Trust (MPW) is $11.33 based on 1-year price targets from 11 Wall Street analysts in the past 3 months, with a price target range of $27.00 to $4.00. This represents a potential 165.96% upside from MPW's last price of $4.26.

MPW Analyst Ratings


Hold

According to 11 Wall Street analysts, Medical Properties Trust's rating consensus is 'Hold'. The analyst rating breakdown for MPW stock is 0 'Strong Buy' (0.00%), 4 'Buy' (36.36%), 6 'Hold' (54.55%), 1 'Sell' (9.09%), and 0 'Strong Sell' (0.00%).

Medical Properties Trust Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Sep 13, 2024Michael LewisTruist Financial$6.00$5.607.14%40.85%
Sep 13, 2024David TotiColliers Securities$6.50$5.6016.07%52.58%
Sep 12, 2024Vikram MalhotraMizuho Securities$7.00$5.6523.85%64.32%
Aug 02, 2024Dori KestenWells Fargo$7.50$4.6361.99%76.06%
Aug 02, 2024Michael LewisTruist Financial$8.00$4.6372.79%87.79%
Jul 01, 2024Nate CrossettBNP Paribas$4.00$4.09-2.20%-6.10%
May 29, 2024Michael LewisTruist Financial$5.00$4.980.40%17.37%
May 13, 2024Michael CarrollRBC Capital$5.00$5.58-10.39%17.37%
Apr 17, 2024Omotayo OkusanyaDeutsche Bank$5.00$4.628.23%17.37%
Apr 08, 2024Michael LewisTruist Financial$4.50$4.0511.11%5.63%
Row per page
Go to

The latest Medical Properties Trust stock forecast, released on Sep 13, 2024 by Michael Lewis from Truist Financial, set a price target of $6.00, which represents a 7.14% increase from the stock price at the time of the forecast ($5.60), and a 40.85% increase from MPW last price ($4.26).

Medical Properties Trust Price Target by Period


1M3M12M
# Anlaysts-310
Avg Price Target-$6.50$5.85
Last Closing Price$4.26$4.26$4.26
Upside/Downside-100.00%52.58%37.32%

In the current month, the average price target of Medical Properties Trust stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Medical Properties Trust's last price of $4.26. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
Sep 13, 2024Colliers Securities-BuyUpgrade
Aug 02, 2024Wells FargoUnderweightUnderweightHold
Aug 02, 2024HSBC-HoldInitialise
Jul 01, 2024Exane BNP ParibasOutperformNeutralDowngrade
May 13, 2024RBC CapitalOutperformSector PerformDowngrade
Apr 17, 2024Deutsche BankUnderweightHoldUpgrade
Mar 01, 2024Exane BNP Paribas-OutperformUpgrade
Feb 05, 2024Wells FargoUnderweightUnderweightHold
Dec 01, 2023Raymond JamesStrong BuyUnderperformDowngrade
Dec 01, 2023BMO CapitalOutperformOutperformHold
Row per page
Go to

Medical Properties Trust's last stock rating was published by Colliers Securities on Sep 13, 2024. The company Upgrade its MPW rating from "null" to "Buy".

Medical Properties Trust Financial Forecast


Medical Properties Trust Revenue Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Revenue------------$-122.38M$306.58M$337.39M$350.21M$380.49M$352.34M$400.23M$409.80M$409.33M$390.78M$381.79M$362.76M$333.81M$329.46M$291.84M$294.13M$256.44M$224.76M
Avg Forecast$290.67M$289.03M$290.87M$283.27M$273.72M$255.92M$257.15M$247.44M$243.82M$254.20M$259.53M$270.14M$300.77M$333.98M$344.44M$347.51M$364.71M$383.57M$394.25M$399.52M$395.11M$379.68M$360.58M$338.50M$327.09M$308.72M$296.23M$298.33M$263.39M$220.43M
High Forecast$293.35M$291.70M$293.55M$285.88M$276.25M$258.28M$259.52M$249.98M$244.31M$257.08M$259.53M$270.14M$401.39M$349.86M$347.62M$350.71M$368.08M$383.57M$394.25M$399.52M$395.11M$379.68M$360.58M$338.50M$327.09M$308.72M$296.23M$298.33M$263.39M$220.43M
Low Forecast$287.42M$285.80M$287.62M$280.10M$270.66M$253.06M$254.28M$244.96M$243.21M$251.33M$259.53M$270.14M$87.15M$320.27M$340.59M$343.62M$360.63M$383.57M$394.25M$399.52M$395.11M$379.68M$360.58M$338.50M$327.09M$308.72M$296.23M$298.33M$263.39M$220.43M
# Analysts111111133122485443435454533322
Surprise %-------------0.41%0.92%0.98%1.01%1.04%0.92%1.02%1.03%1.04%1.03%1.06%1.07%1.02%1.07%0.99%0.99%0.97%1.02%

Medical Properties Trust's average Quarter revenue forecast for Mar 24 based on 2 analysts is $270.14M, with a low forecast of $270.14M, and a high forecast of $270.14M. MPW's average Quarter revenue forecast represents a -320.73% decrease compared to the company's last Quarter revenue of $-122.38M (Dec 23).

Medical Properties Trust EBITDA Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts111111133122485443435454533322
EBITDA------------$-582.31M$315.23M$173.71M$390.85M$612.88M$341.75M$356.43M$368.19M$299.01M$270.18M$243.81M$250.75M$191.26M$301.95M$259.06M$229.73M$246.31M$195.20M
Avg Forecast$247.99M$246.59M$248.16M$241.67M$233.53M$218.34M$219.39M$211.11M$208.02M$216.88M$221.42M$230.47M$256.61M$284.94M$293.86M$296.48M$297.08M$93.14M$95.73M$97.01M$95.94M$92.19M$87.56M$231.46M$79.42M$74.96M$71.93M$72.44M$63.96M$53.52M
High Forecast$250.27M$248.87M$250.45M$243.90M$235.68M$220.35M$221.42M$213.27M$208.43M$219.33M$221.42M$230.47M$342.45M$298.48M$296.57M$299.21M$356.49M$93.14M$95.73M$97.01M$95.94M$92.19M$87.56M$277.75M$79.42M$74.96M$71.93M$72.44M$63.96M$53.52M
Low Forecast$245.21M$243.84M$245.38M$238.97M$230.92M$215.90M$216.94M$208.99M$207.50M$214.43M$221.42M$230.47M$74.35M$273.24M$290.58M$293.16M$237.66M$93.14M$95.73M$97.01M$95.94M$92.19M$87.56M$185.17M$79.42M$74.96M$71.93M$72.44M$63.96M$53.52M
Surprise %-------------2.27%1.11%0.59%1.32%2.06%3.67%3.72%3.80%3.12%2.93%2.78%1.08%2.41%4.03%3.60%3.17%3.85%3.65%

4 analysts predict MPW's average Quarter EBITDA for Dec 23 to be $256.61M, with a high of $342.45M and a low of $74.35M. This is -18.60% lower than Medical Properties Trust's previous annual EBITDA (Sep 23) of $315.23M.

Medical Properties Trust Net Income Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts111111133122485443435454533322
Net Income------------$-655.62M$116.71M$-338.96M$32.79M$-140.21M$221.79M$189.60M$631.68M$206.84M$171.14M$114.56M$163.78M$109.88M$131.11M$109.47M$80.99M$129.64M$89.79M
Avg Forecast$18.01M$6.00M$-6.00M$6.00M$39.01M$24.01M$15.00M$15.00M$11.81M$14.60M$26.69M$1.06B$87.60M$114.91M$130.69M$963.82M$205.20M$180.88M$177.31M$876.20M$186.47M$169.10M$171.17M$151.18M$159.86M$154.77M$153.44M$106.74M$138.75M$126.34M
High Forecast$18.22M$6.07M$-5.91M$6.07M$39.48M$24.30M$15.18M$17.65M$13.20M$14.78M$26.83M$1.27B$103.82M$120.96M$132.25M$1.16B$246.24M$180.88M$177.31M$1.05B$186.47M$169.10M$171.17M$181.42M$159.86M$154.77M$153.44M$128.08M$138.75M$126.34M
Low Forecast$17.74M$5.91M$-6.07M$5.91M$38.45M$23.66M$14.79M$13.24M$11.12M$14.39M$26.55M$848.16M$77.86M$102.81M$128.79M$771.06M$164.16M$180.88M$177.31M$700.96M$186.47M$169.10M$171.17M$120.95M$159.86M$154.77M$153.44M$85.39M$138.75M$126.34M
Surprise %-------------7.48%1.02%-2.59%0.03%-0.68%1.23%1.07%0.72%1.11%1.01%0.67%1.08%0.69%0.85%0.71%0.76%0.93%0.71%

Medical Properties Trust's average Quarter net income forecast for Dec 23 is $87.60M, with a range of $77.86M to $103.82M. MPW's average Quarter net income forecast represents a -24.94% decrease compared to the company's last Quarter net income of $116.71M (Sep 23).

Medical Properties Trust SG&A Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts111111133122485443435454533322
SG&A------------$30.15M$38.11M$35.60M$41.72M$42.89M$37.32M$38.86M$41.42M$38.33M$36.69M$34.55M$36.07M$106.74M$101.38M$93.48M$94.31M$71.55M$64.12M
Avg Forecast$33.92M$33.73M$33.95M$33.06M$31.95M$29.87M$30.01M$28.88M$28.46M$29.67M$30.29M$69.53M$35.10M$38.98M$40.20M$63.21M$38.08M$44.77M$46.01M$57.46M$46.11M$44.31M$42.08M$33.30M$38.18M$36.03M$34.57M$124.28M$30.74M$25.73M
High Forecast$34.24M$34.05M$34.26M$33.37M$32.24M$30.14M$30.29M$29.18M$28.51M$30.00M$30.29M$83.43M$46.85M$40.83M$40.57M$75.85M$45.69M$44.77M$46.01M$68.95M$46.11M$44.31M$42.08M$39.96M$38.18M$36.03M$34.57M$149.14M$30.74M$25.73M
Low Forecast$33.55M$33.36M$33.57M$32.69M$31.59M$29.54M$29.68M$28.59M$28.39M$29.33M$30.29M$55.62M$10.17M$37.38M$39.75M$50.56M$30.46M$44.77M$46.01M$45.97M$46.11M$44.31M$42.08M$26.64M$38.18M$36.03M$34.57M$99.43M$30.74M$25.73M
Surprise %------------0.86%0.98%0.89%0.66%1.13%0.83%0.84%0.72%0.83%0.83%0.82%1.08%2.80%2.81%2.70%0.76%2.33%2.49%

Medical Properties Trust's average Quarter SG&A projection for Mar 24 is $69.53M, based on 2 Wall Street analysts, with a range of $55.62M to $83.43M. The forecast indicates a 130.60% rise compared to MPW last annual SG&A of $30.15M (Dec 23).

Medical Properties Trust EPS Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts111111133122485443435454533322
EPS------------$-1.09$0.19$-0.57$0.06$-0.23$0.37$0.32$1.05$0.35$0.29$0.19$0.28$0.20$0.25$0.21$0.15$0.26$0.20
Avg Forecast$0.03$0.01$-0.01$0.01$0.07$0.04$0.03$0.03$0.02$0.02$0.04$0.09$0.15$0.19$0.22$0.22$0.27$0.30$0.30$0.31$0.31$0.28$0.29$0.26$0.27$0.26$0.26$0.28$0.23$0.21
High Forecast$0.03$0.01$-0.01$0.01$0.07$0.04$0.03$0.03$0.02$0.02$0.04$0.09$0.17$0.20$0.22$0.23$0.28$0.30$0.30$0.31$0.31$0.28$0.29$0.26$0.27$0.26$0.26$0.28$0.23$0.21
Low Forecast$0.03$0.01$-0.01$0.01$0.06$0.04$0.02$0.02$0.02$0.02$0.04$0.09$0.13$0.17$0.21$0.22$0.27$0.30$0.30$0.31$0.31$0.28$0.29$0.26$0.27$0.26$0.26$0.28$0.23$0.21
Surprise %-------------7.47%0.99%-2.62%0.25%-0.84%1.23%1.08%3.44%1.13%1.03%0.67%1.07%0.75%0.97%0.82%0.53%1.12%0.95%

According to 4 Wall Street analysts, Medical Properties Trust's projected average Quarter EPS for Dec 23 is $0.15, with a low estimate of $0.13 and a high estimate of $0.17. This represents a -23.18% decrease compared to MPW previous annual EPS of $0.19 (Sep 23).

Medical Properties Trust Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
MPWMedical Properties Trust$4.26$11.33165.96%Hold
GMREGlobal Medical REIT$8.64$11.7536.00%Buy
CHCTCommunity Healthcare Trust$18.39$22.3321.42%Buy
HRHealthcare Realty Trust$17.56$19.008.20%Buy
LTCLTC Properties$38.37$38.25-0.31%Hold
OHIOmega Healthcare Investors$39.88$38.62-3.16%Buy
VTRVentas$64.11$61.34-4.32%Buy
SBRASabra Health Care REIT$18.39$17.29-5.98%Hold
NHINational Health Investors$77.14$72.20-6.40%Hold
CTRECareTrust REIT$30.66$25.50-16.83%Buy

MPW Forecast FAQ


Is Medical Properties Trust a good buy?

No, according to 11 Wall Street analysts, Medical Properties Trust (MPW) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 4 'Buy' recommendations, accounting for 36.36% of MPW's total ratings.

What is MPW's price target?

Medical Properties Trust (MPW) average price target is $11.33 with a range of $4 to $27, implying a 165.96% from its last price of $4.26. The data is based on 11 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Medical Properties Trust stock go up soon?

According to Wall Street analysts' prediction for MPW stock, the company can go up by 165.96% (from the last price of $4.26 to the average price target of $11.33), up by 533.80% based on the highest stock price target, and down by -6.10% based on the lowest stock price target.

Can Medical Properties Trust stock reach $6?

MPW's average twelve months analyst stock price target of $11.33 supports the claim that Medical Properties Trust can reach $6 in the near future.

What are Medical Properties Trust's analysts' financial forecasts?

Medical Properties Trust's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $1.03B (high $1.04B, low $1.02B), average EBITDA is $882.36M (high $890.73M, low $872.75M), average net income is $93.03M (high $96.61M, low $90.13M), average SG&A $120.71M (high $121.85M, low $119.39M), and average EPS is $0.155 (high $0.161, low $0.15). MPW's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $1.15B (high $1.16B, low $1.14B), average EBITDA is $984.41M (high $993.49M, low $973.4M), average net income is $24.01M (high $24.46M, low $23.5M), average SG&A $134.67M (high $135.91M, low $133.16M), and average EPS is $0.04 (high $0.0407, low $0.0392).

Did the MPW's actual financial results beat the analysts' financial forecasts?

Based on Medical Properties Trust's last annual report (Dec 2023), the company's revenue was $871.8M, which missed the average analysts forecast of $1.33B by -34.29%. Apple's EBITDA was $-83.411M, missing the average prediction of $1.13B by -107.37%. The company's net income was $-817M, missing the average estimation of $1.3B by -163.03%. Apple's SG&A was $145.59M, missing the average forecast of $177.49M by -17.97%. Lastly, the company's EPS was $-1.37, missing the average prediction of $0.778 by -276.19%. In terms of the last quarterly report (Dec 2023), Medical Properties Trust's revenue was $-122M, missing the average analysts' forecast of $300.77M by -140.69%. The company's EBITDA was $-582M, missing the average prediction of $256.61M by -326.93%. Medical Properties Trust's net income was $-656M, missing the average estimation of $87.6M by -848.44%. The company's SG&A was $30.15M, missing the average forecast of $35.1M by -14.11%. Lastly, the company's EPS was $-1.09, missing the average prediction of $0.146 by -846.83%